Created at Source Raw Value Validated value
June 25, 2024, noon usa

* inflammatory bowel disease * history of gastric bypass surgery * active clostridium difficile infection * active participation in another covid-19 interventional trial * any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with the protocol procedures. * reported allergy to starch * difficulty swallowing in order to prevent any aspiration risk * currently taking any il-6 inhibitors such as tocilizumab for any disease condition

* inflammatory bowel disease * history of gastric bypass surgery * active clostridium difficile infection * active participation in another covid-19 interventional trial * any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with the protocol procedures. * reported allergy to starch * difficulty swallowing in order to prevent any aspiration risk * currently taking any il-6 inhibitors such as tocilizumab for any disease condition

Oct. 26, 2020, 11:31 p.m. usa

- inflammatory bowel disease - history of gastric bypass surgery - active clostridium difficile infection - active participation in another covid-19 interventional trial - any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with the protocol procedures. - reported allergy to starch - difficulty swallowing in order to prevent any aspiration risk - currently taking any il-6 inhibitors such as tocilizumab for any disease condition

- inflammatory bowel disease - history of gastric bypass surgery - active clostridium difficile infection - active participation in another covid-19 interventional trial - any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with the protocol procedures. - reported allergy to starch - difficulty swallowing in order to prevent any aspiration risk - currently taking any il-6 inhibitors such as tocilizumab for any disease condition